Trading Directions
Mesoblast (MESO) Spikes On FDA’s Endorsement For Accelerated Approval
Mesoblast Limited (NASDAQ: MESO) is witnessing a significant surge in its stock during the current trading session, experiencing a noteworthy increase of 31.16% to reach